financetom
Business
financetom
/
Business
/
Zara owner Inditex's profit rises to 5.4 billion euros in 2023 on bet on upmarket fashion and competitive prices
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zara owner Inditex's profit rises to 5.4 billion euros in 2023 on bet on upmarket fashion and competitive prices
Mar 13, 2024 12:03 AM

(Corrects headline to show profit rose, not rose/fell)

MADRID (Reuters) - Zara owner Inditex said on Wednesday its net income for 2023 rose to 5.4 billion euros as the fast-fashion giant bet on upmarket shoppers and offered more competitive prices than rivals such as H&M.

The company's profit for the fiscal year ending in January was in line with analyst expectations in an LSEG poll.

(This story has been corrected to specify that profit rose, in the headline)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products
MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products
Mar 27, 2024
03:06 PM EDT, 03/27/2024 (MT Newswires) -- MiMedx Group ( MDXG ) said Wednesday the US Food and Drug Administration affirmed that Axiofill, a human-derived particulate wound dressing, does not meet the regulatory requirements as a Human Cell, Tissue or Cellular or Tissue-based Product under Section 361 of the Public Health Service Act. The FDA issued its decision in a...
National Bank Reviews Pivotree's Q4 -- Trims Target to $3, Reiterates Outperform
National Bank Reviews Pivotree's Q4 -- Trims Target to $3, Reiterates Outperform
Mar 27, 2024
03:01 PM EDT, 03/27/2024 (MT Newswires) -- Pivotree ( PVTRF ) reported its Q4 results with soft top-line performance care of macro-related project delays and the continued transition away from legacy solutions. The company was able to offset that softness with cost optimizations and still delivered a positive adj. EBITDA. The sequential growth in the leading indicator PS bookings suggests...
Merck's Winrevair Poised for Strong Launch Following US FDA Approval, UBS Says
Merck's Winrevair Poised for Strong Launch Following US FDA Approval, UBS Says
Mar 27, 2024
03:09 PM EDT, 03/27/2024 (MT Newswires) -- Merck's ( MRK ) Winrevair is poised for a strong launch after the US Food and Drug Administration approved the medicine with a clean label and no significant warning or risk evaluation and mitigation strategy program, UBS said in a note emailed Wednesday. Noting that concerns of potential gastrointestinal bleeding as a result...
Market Chatter: Artisan Partners Asset Management Increases Stake in Barry Callebaut
Market Chatter: Artisan Partners Asset Management Increases Stake in Barry Callebaut
Mar 27, 2024
02:59 PM EDT, 03/27/2024 (MT Newswires) -- Artisan Partners Asset Management ( APAM ) increased its shareholding in Barry Callebaut to 5.5% from 3% in February, Bloomberg News reported, citing SIX Exchange. Artisan Partners is the second largest stakeholder in the Swiss-Belgian chocolate maker behind Jacobs Holding, which owns a 30% stake, according to the report. Neither Artisan Partners nor...
Copyright 2023-2024 - www.financetom.com All Rights Reserved